Increased concentrations of EVs exposing VE-cadherin were found in patients with obstructive CAD, chronic heart failure, acute ischemic stroke and heart transplant recipients with graft vasculopathy, compared to healthy controls [13]. This evidence concerns the gene CDH5 and vascular disorder.